» Articles » PMID: 20046837

P19 H-ras Induces G1/S Phase Delay Maintaining Cells in a Reversible Quiescence State

Overview
Journal PLoS One
Date 2010 Jan 5
PMID 20046837
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Three functional c-ras genes, known as c-H-ras, c-K-ras, and c-N-ras, have been largely studied in mammalian cells with important insights into normal and tumorigenic cellular signal transduction events. Two K-Ras mRNAs are obtained from the same pre-mRNA by alternative splicing. H-Ras pre-mRNA can also be alternatively spliced in the IDX and 4A terminal exons, yielding the p19 and p21 proteins, respectively. However, despite the Ras gene family's established role in tumorigenic cellular signal transduction events, little is known about p19 function. Previous results showed that p19 did not interact with two known p21 effectors, Raf1 and Rin1, but was shown to interact with RACK1, a scaffolding protein that promotes multi-protein complexes in different signaling pathways (Cancer Res 2003, 63 p5178). This observation suggests that p19 and p21 play differential and complementary roles in the cell.

Principal Findings: We found that p19 regulates telomerase activity through its interaction with p73alpha/beta proteins. We also found that p19 overexpression induces G1/S phase delay; an observation that correlates with hypophosphorylation of both Akt and p70SK6. Similarly, we also observed that FOXO1 is upregulated when p19 is overexpressed. The three observations of (1) hypophosphorylation of Akt, (2) G1/S phase delay and (3) upregulation of FOXO1 lead us to conclude that p19 induces G1/S phase delay, thereby maintaining cells in a reversible quiescence state and preventing entry into apoptosis. We then assessed the effect of p19 RNAi on HeLa cell growth and found that p19 RNAi increases cell growth, thereby having the opposite effect of arrest of the G1/S phase or producing a cellular quiescence state.

Significance: Interestingly, p19 induces FOXO1 that in combination with the G1/S phase delay and hypophosphorylation of both Akt and p70SK6 leads to maintenance of a reversible cellular quiescence state, thereby preventing entry into apoptosis.

Citing Articles

The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.

Chen X, Yang H, Zhang B, Phillips J, Cheng D, Rigo F Proc Natl Acad Sci U S A. 2023; 120(28):e2220190120.

PMID: 37399401 PMC: 10334793. DOI: 10.1073/pnas.2220190120.


MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors.

Urbanski L, Brugiolo M, Park S, Angarola B, Leclair N, Yurieva M Cell Rep. 2022; 41(8):111704.

PMID: 36417849 PMC: 9731204. DOI: 10.1016/j.celrep.2022.111704.


P68 RNA Helicase (DDX5) Required for the Formation of Various Specific and Mature miRNA Active RISC Complexes.

Kokolo M, Bach-Elias M Microrna. 2022; 11(1):36-44.

PMID: 35184719 PMC: 10556402. DOI: 10.2174/2211536611666220218121640.


Splice variants of RAS-translational significance.

Raso E Cancer Metastasis Rev. 2020; 39(4):1039-1049.

PMID: 32772213 PMC: 7680328. DOI: 10.1007/s10555-020-09920-8.


Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.

Justin S, Rutz J, Maxeiner S, Chun F, Juengel E, Blaheta R Int J Mol Sci. 2020; 21(11).

PMID: 32512849 PMC: 7312500. DOI: 10.3390/ijms21114026.


References
1.
Guil S, Gattoni R, Carrascal M, Abian J, Stevenin J, Bach-Elias M . Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol Cell Biol. 2003; 23(8):2927-41. PMC: 152554. DOI: 10.1128/MCB.23.8.2927-2941.2003. View

2.
Cohen J, Broz S, Levinson A . Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell. 1989; 58(3):461-72. DOI: 10.1016/0092-8674(89)90427-3. View

3.
Kim J, Kim W, Jeong M, Jang S, Song K, Park S . p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway. Biochem Biophys Res Commun. 2008; 373(1):146-50. DOI: 10.1016/j.bbrc.2008.06.010. View

4.
Pells S, Divjak M, Romanowski P, Impey H, Hawkins N, Clarke A . Developmentally-regulated expression of murine K-ras isoforms. Oncogene. 1997; 15(15):1781-6. DOI: 10.1038/sj.onc.1201354. View

5.
Rahman-Roblick R, Roblick U, Hellman U, Conrotto P, Liu T, Becker S . p53 targets identified by protein expression profiling. Proc Natl Acad Sci U S A. 2007; 104(13):5401-6. PMC: 1828709. DOI: 10.1073/pnas.0700794104. View